Attention-Deficit/Hyperactivity Disorder

Phase 3 Study of Kapvay for ADHD

Shionogi Inc. announced that data from its Phase 3 study of Kapvay (clonidine hydrochloride) extended-release tablets combined with stimulant medications for the treatment of attention deficit hyperactivity disorder in children and adolescents 6-17 years of age.

INTUNIV (guanfacine) 1mg, 2mg, 3mg, 4mg ext-rel tablets by Shire

Intuniv gains indication as adjunctive therapy in ADHD

Shire announced that the FDA has approved Intuniv (guanfacine extended-release tablets) for use as adjunctive therapy to stimulants for the treatment of attention deficit hyperactivity disorder (ADHD) in children and adolescents 6-17 years as part of a total treatment program.

KAPVAY (clonidine HCl) 0.1mg, 0.2mg extended-release tablets by Shionogi

Kapvay available for ADHD

Shionogi announced the availability of Kapvay (clonidine HCl extended-release tablets) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents ages 6-17 years old.

Vyvanse gains indication for ADHD in adolescents

The FDA has approved Vyvanse (lisdexamfetamine dimesylate capsules, from Shire) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adolescents 13-17 years of age.

KAPVAY (clonidine HCl) 0.1mg, 0.2mg extended-release tablets by Shionogi

Kapvay approved for ADHD

The FDA has approved Kapvay (clonidine HCl extended-release tablets, from Shionogi) for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents ages 6-17 years old.

CDC issues statement and recommendations regarding prescription drug misuse

The CDC announced the 2009 National Youth Risk Behavior Survey (YRBS) found that 1 in 5 high school students have ever taken a prescription drug such as OxyContin (oxycodone, from Purdue), Percocet (oxycodone/acetaminophen, from Endo), Vicodin (hydrocodone/acetaminophen, from Abbott), Adderall (mixed salts of a single-entity amphetamine product, from Shire), Ritalin (methylphenidate, from Novartis), or Xanax (alprazolam, from Pfizer), without a prescription.